John A. Levi
- Oncology top 1%
- Neutropenia and Cancer Infections 15
- Cancer Treatment and Pharmacology 11
-
- Lymphoma Diagnosis and Treatment 10
-
- Lung Cancer Treatments and Mutations 7
- Gastric Cancer Management and Outcomes 5
- Genetics top 5%
- Geriatrics and Gerontology top 5%
-
- Testicular diseases and treatments 9
-
- Palliative Care and End-of-Life Issues 6
-
- Cancer therapeutics and mechanisms 6
- Co-authors
- Peter H. WiernikAnnette J. DobsonB. R. CatchloveWalter O. SpitzerJane HallRenaldo N. BattistaDavid BellRobert L. Woods
- Journals
- The Medical Journal of Australia (12 papers)Cancer (11 papers)Journal of Clinical Oncology (5 papers)
- Partner nations
- AustraliaUnited StatesIsrael
In The Last Decade
John A. Levi
98 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Oncology 1.7k
- Pathology and Forensic Medicine 653
- Pulmonary and Respiratory Medicine 1.0k
- Genetics 272
- Geriatrics and Gerontology 92
Countries citing papers authored by John A. Levi
This map shows the geographic impact of John A. Levi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Levi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Levi more than expected).
Fields of papers citing papers by John A. Levi
This network shows the impact of papers produced by John A. Levi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Levi. The network helps show where John A. Levi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John A. Levi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2010 | 49 | |
| 3 | 2001 | 108 | |
| 4 | 1999 | 63 | |
| 5 | 1999 | 12 | |
| 6 | A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer : Preliminary results | 1997 | 6 |
| 7 | 1994 | 11 | |
| 8 | 1992 | 15 | |
| 9 | 1990 | 114 | |
| 10 | 1990 | 3 | |
| 11 | 1990 | 15 | |
| 12 | 1988 | 48 | |
| 13 | 1987 | 1 | |
| 14 | Deletion of Bleomycin From Therapy for Good Prognosis Advanced Testicular Cancer - a Prospective Randomized Study | 1986 | 13 |
| 15 | 1983 | 3 | |
| 16 | 1982 | 9 | |
| 17 | 1982 | 18 | |
| 18 | 1979 | 42 | |
| 19 | 1979 | 3 | |
| 20 | 1973 | 62 |
About John A. Levi
John A. Levi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 99 papers that have together received 4.2k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (15 papers), Cancer Treatment and Pharmacology (11 papers), Lymphoma Diagnosis and Treatment (10 papers), Testicular diseases and treatments (9 papers), Lung Cancer Treatments and Mutations (7 papers), Palliative Care and End-of-Life Issues (6 papers), Cancer therapeutics and mechanisms (6 papers) and Gastric Cancer Management and Outcomes (5 papers). The work is most often cited by research in Oncology (1.7k citations), Pathology and Forensic Medicine (653 citations) and Pulmonary and Respiratory Medicine (1.0k citations). John A. Levi has collaborated with scholars based in Australia, United States and Israel. Frequent co-authors include Peter H. Wiernik, Annette J. Dobson, B. R. Catchlove, Walter O. Spitzer, Jane Hall, Renaldo N. Battista, David Bell, Robert L. Woods, D. Dalley and Nick Pavlakis. Their work appears in journals such as The Medical Journal of Australia, Cancer, Journal of Clinical Oncology, British Journal of Haematology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.